141 filings
Page 3 of 8
8-K
moweowfp7 ewd
26 Sep 18
Entry into a Material Definitive Agreement
12:00am
8-K
ujj06jc65so2 rqwjlf0
31 Jul 18
Entry into a Material Definitive Agreement
4:52pm
8-K/A
fbmay fp6qzztn01t
2 Jul 18
Index to Financial Statements
4:05pm
8-K
uuvpdw
16 May 18
Regulation FD Disclosure
3:12pm
8-K
wx13c h4fkyt
15 May 18
Departure of Directors or Certain Officers
12:00am
8-K
2ev9j v1el6tz43y
14 Mar 18
Entry into a Material Definitive Agreement
12:00am
8-K
wge8z8z5p
30 Jan 18
Entry into a Material Definitive Agreement
12:00am
8-K
kw1om9b7ejjo
29 Dec 17
Cost Associated with Exit or Disposal Activities
12:00am
8-K
gkux1emo 2wq
26 Jul 17
Entry into a Material Definitive Agreement
12:00am
8-K
6pvr oxyqh7wbvinixe0
6 Jun 17
Entry into a Material Definitive Agreement
12:00am
8-K
ms8ww3ha16guxu14sa
21 Apr 17
Departure of Directors or Certain Officers
12:00am
8-K/A
c8ex i13x
31 Mar 17
Financial Statements and Exhibits
12:00am
8-K
lwrttw32kduyk
13 Mar 17
OncBioMune Acquires Vitel Laboratorios, Gains Two Revenue Generating Drugs, Robust Pipeline and Extensive Distribution Network
12:00am
8-K
we5n8ievmnoa7a
28 Nov 16
Entry into a Material Definitive Agreement
12:00am
8-K
idvxfnrblzplxdr5ms5n
3 Nov 16
Regulation FD Disclosure
12:00am
8-K
c76uhv8j r6d8
14 Sep 16
Regulation FD Disclosure
12:00am
8-K
frgu7 u5o4lh5h5xd
26 Aug 16
Financial Statements and Exhibits
12:00am
8-K
m65lr2h9ch
5 Feb 16
Departure of Directors or Certain Officers
12:00am
8-K
yrxce2
22 Jan 16
OncBioMune Receives Notice of Allowance for Patent Covering New Targeted Cancer Treatments
12:00am
8-K
wexl6p975 diom551d
5 Jan 16
Unregistered Sales of Equity Securities
12:00am